Patients report health problems from unregulated peptides as RFK Jr. pushes to expand access
People who have taken experimental peptides report adverse effects including migraines, eye pain, and fatigue, even as Health Secretary Robert F. Kennedy Jr. seeks to loosen regulations and lower barriers to accessing these FDA-unapproved substances. Medical experts warn that vague symptoms from gray market peptides often go unrecognized or unreported.